EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A single residue in domain II of envelope protein of yellow fever virus is critical for neutralization sensitivity

Ya-Nan Lou iD, Meng-Xu Sun, Kai Li, Xiao-Chuan Xiong, Chao Zhou, Tian-Shu Cao, Xiao-Feng Li iD, Cheng-Feng Qin iD

Journal of Virology · 2025

DOI: 10.1128/jvi.01770-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, 2025. Verfasst von Ya-Nan Lou und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing, China. Hauptthemen laut MEDLINE: Yellow fever virus, Antibodies, Neutralizing, Viral Envelope Proteins, Antibodies, Viral. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The National Science Fund for Distinguished Young Scholars, The Innovation Fund for Medical Sciences, MOST | National Key Research and Development Program of China (NKPs).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The live-attenuated yellow fever (YF) vaccine strain 17D (referred to as YF-17D) is the only commercially available vaccine against YF. Recent yellow fever virus (YFV) isolates of South American genotype I (SAI) showed reduced sensitivity to sera from individuals vaccinated with YF-17D. However, the underlying mechanisms remain inadequately elucidated. Here we conducted a screening of a panel of amino acid changes prevalent in domain II of the envelope protein (EDII) of SAI YFV isolates. Each mutation was introduced into the infectious clone of YF-17D utilizing standard reverse genetics. Subsequent neutralization assays demonstrated that the A83E mutant was more sensitive to sera from YF-17D-vaccinated mice and individuals than YF-17D did. Additionally, the A83E mutant displayed neurovirulence and viscerotropic characteristics comparable to those of the parental YF-17D in murine models. Notably, administration of a single dose of the A83E mutant resulted in an enhanced neutralization response against this variant compared to YF-17D and provided complete protection against lethal YFV challenge in mice. Collectively, these findings not only identify a crucial amino acid residue that influences the neutralization sensitivity of YFV but also provide a promising candidate for the development of an updated YF vaccine. IMPORTANCE The YF-17D vaccine has been used to prevent YF disease. However, recent strains belonging to the SAI displayed reduced sensitivity to the antibodies produced by vaccination, raising concerns about potential future outbreaks. To identify potential amino acid residues responsible for the decreased neutralizing activity of YF-17D-vaccinated sera, we conducted a screening and generated recombinant viruses with amino acid changes specific to the SAI in EDII using the YF-17D genome as a genetic backbone. We found the A83E mutation played a key role in reducing neutralizing sensitivity to YF-17D-vaccinated mouse sera. Importantly, the A83E mutant maintained a comparable attenuation phenotype to YF-17D but elicited enhanced neutralization activity and conferred protection in mice. Together, we identify a key amino acid residue responsible for the neutralization escape of SAI YFV isolates. We propose that this substitution could act as a target for developing an updated YF-17D vaccine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Yellow fever virusAntibodies, NeutralizingViral Envelope ProteinsAntibodies, ViralYellow FeverYellow Fever VaccineAnimalsMiceNeutralization TestsHumansVaccines, AttenuatedFemaleMutationMice, Inbred BALB CProtein Domains

Stichwörter der Autor:innen

neurovirulenceneutralization escapevaccinationyellow fever

Substanzen

Antibodies, NeutralizingViral Envelope ProteinsAntibodies, ViralYellow Fever VaccineVaccines, Attenuated

Autor:innen und Institutionen

  • State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing, China.
  • Research Unit of Discovery and Tracing of Natural Focus Diseases, Chinese Academy of Medical Sciences, Beijing, China.

ORCID-Profile: Ya-Nan Lou, Xiao-Feng Li, Cheng-Feng Qin

Förderung

  • The National Science Fund for Distinguished Young Scholars
  • The Innovation Fund for Medical Sciences
  • MOST | National Key Research and Development Program of China (NKPs)
  • MOST | National Natural Science Foundation of China (NSFC)

Zitieren

APA

Lou, Y. N., Sun, M. X., Li, K., Xiong, X. C., Zhou, C., Cao, T. S., Li, X. F., & Qin, C. F. (2025). A single residue in domain II of envelope protein of yellow fever virus is critical for neutralization sensitivity. Journal of Virology. https://doi.org/10.1128/jvi.01770-24

Vancouver

Lou YN, Sun MX, Li K, Xiong XC, Zhou C, Cao TS, et al. A single residue in domain II of envelope protein of yellow fever virus is critical for neutralization sensitivity. Journal of Virology. 2025. doi:10.1128/jvi.01770-24

BibTeX
@article{Lou2025,
  author = {Lou, Ya-Nan and Sun, Meng-Xu and Li, Kai and Xiong, Xiao-Chuan and Zhou, Chao and Cao, Tian-Shu and Li, Xiao-Feng and Qin, Cheng-Feng},
  title = {A single residue in domain II of envelope protein of yellow fever virus is critical for neutralization sensitivity},
  journal = {Journal of Virology},
  year = {2025},
  doi = {10.1128/jvi.01770-24}
}
Kostenlos starten →